Worth Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.96M Buy
1,633
+24
+1% +$24.5K 0.63% 30
2026
Q1
$1.48M Sell
1,609
-1,089
-40% -$1.1M 0.55% 45
2025
Q4
$2.9M Buy
2,698
+1,142
+73% +$1.09M 1.23% 18
2025
Q3
$1.19M Sell
1,556
-9
-0.6% -$6.7K 0.53% 35
2025
Q2
$1.22M Sell
1,565
-1,817
-54% -$1.41M 0.6% 33
2025
Q1
$2.79M Buy
3,382
+1,843
+120% +$1.53M 1.53% 14
2024
Q4
$1.19M Sell
1,539
-91
-6% -$75.3K 0.63% 38
2024
Q3
$1.44M Sell
1,630
-111
-6% -$99.8K 0.79% 32
2024
Q2
$1.58M Sell
1,741
-10
-0.6% -$8K 0.94% 28
2024
Q1
$1.36M Buy
1,751
+224
+15% +$159K 0.84% 30
2023
Q4
$890K Sell
1,527
-2,387
-61% -$1.39M 0.64% 43
2023
Q3
$2.1M Buy
3,914
+3,559
+1,003% +$1.83M 1.7% 11
2023
Q2
$166K Buy
355
+236
+198% +$99K 0.13% 91
2023
Q1
$40.9K Sell
119
-112
-48% -$37.8K 0.03% 194
2022
Q4
$84.5K Buy
231
+190
+463% +$67.4K 0.06% 136
2022
Q3
$14K Sell
41
-2,349
-98% -$744K 0.01% 249
2022
Q2
$775K Sell
2,390
-2,813
-54% -$844K 0.53% 35
2022
Q1
$1.52M Buy
+5,203
New +$1.34M 0.99% 27

Other funds holding LLY

Worth Asset Management's LLY Position: Q2 2026 in Review

Worth Asset Management increased its Eli Lilly (LLY) stake by 1.5% in Q2 2026, buying an estimated $24.5K and bringing the position to 1,633 shares worth $1.96M. The position accounts for 0.63% of the portfolio, ranked #30.

Worth Asset Management first reported a position in LLY in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.9M in Q4 2025. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Worth Asset Management held 1,633 shares of Eli Lilly worth $1.96M as of Q2 2026.
  • Worth Asset Management bought 24 Eli Lilly shares in Q2 2026, an estimated $24.5K.
  • Eli Lilly made up 0.63% of Worth Asset Management's portfolio in Q2 2026, its #30 holding.
  • Worth Asset Management first reported a position in Eli Lilly in Q1 2022 and has held it in 18 quarters since.
  • Worth Asset Management's Eli Lilly position peaked at $2.9M in Q4 2025.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Worth Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.